HAUMANN BRETT K 4
4 · Theravance Biopharma, Inc. · Filed Nov 22, 2019
Insider Transaction Report
Form 4
HAUMANN BRETT K
SVP, Clinical Development
Transactions
- Tax Payment
Ordinary Shares
2019-11-20$17.60/sh−2,692$47,379→ 231,276 total
4 · Theravance Biopharma, Inc. · Filed Nov 22, 2019
Ordinary Shares